Matthew Cohn of
Philadelphia will head the
non-profit's volunteer-led Global Mission Board which
focuses on special initiatives in type 1 diabetes research,
fundraising, community engagement, and advocacy
NEW
YORK, July 10, 2024 /PRNewswire/
-- Breakthrough T1D, formerly JDRF, the leading global type 1
diabetes (T1D) research and advocacy organization, today announced
the appointment of Matthew Cohn as
the new chair of the non-profit's Global Mission Board.
Breakthrough T1D's Global Mission Board is a volunteer-led group,
appointed by the organization's board of directors, that focuses on
special initiatives in type 1 diabetes research, fundraising,
community engagement and advocacy. Matthew is the father of two
daughters, Sydney and Mackenzie Skylar, who live with T1D, and has
been a Breakthrough T1D volunteer since 2007. He is vice chairman
of the ASI family of companies, the leading media, information and
technology company serving the promotional products
industry.
"Breakthrough T1D is fueled by thousands of engaged and
passionate volunteers. Our Global Mission Board harnesses the
talents of some of our most prolific volunteers and is an essential
part of our organization," said Aaron J.
Kowalski, Ph.D., chief executive officer of Breakthrough
T1D. "We are thrilled that Matthew is taking on the role of chair
of Breakthrough T1D's Global Mission Board. I look forward to his
partnership as we move closer to a world without type 1
diabetes."
In addition to his work with the Global Mission Board, Matthew
is a past member of Breakthrough T1D's International Board of
Directors and has served as president of Breakthrough T1D's Eastern
Pennsylvania Chapter.
"I have been a Breakthrough T1D volunteer for nearly 20 years
and have seen amazing progress driven by the volunteers and staff
of the organization. I am honored to have been chosen to continue
the great work of outgoing chair, Jennifer
Bennett and step into the role of chair of the Global
Mission Board," said Matthew Cohn.
"Working in partnership with my fellow board members, I look
forward to leveraging our volunteerism as we support Breakthrough
T1D's incredible mission of accelerating life-changing
breakthroughs to cure, prevent, and treat type 1 diabetes and its
complications."
Matthew, who is married to his childhood sweetheart Lea, is a
graduate of the Wharton School of Business of the University of Pennsylvania and brings a depth of
successfully business and volunteer leadership experience to
Breakthrough T1D. He was named one of the "Top 100 People to Watch"
by Business Philadelphia magazine, as well as one of the "100 Most
Influential People" in the trade-show industry by Tradeshow Week.
He has founded and helped lead organizations in diverse industries,
including technology, media, events, medical information, fintech,
and banking, and led the ASI Show to be twice named to the INC 500
list of the fastest growing private companies in North America. Matthew is a Director
of The Bancorp (NASDAQ: TBBK), a technology bank / Fintech,
which in 2020, ranked number 28 on Fortune's 100
Fastest-Growing Companies - the list ranking the world's top
performing, publicly traded companies. At Bancorp he serves on
the Audit, Compensation, & NomGov committees and is chair of
the ESG committee.
In addition to his non-profit board experience with Breakthrough
T1D, Matthew has been on the boards of multiple other leading
non-profit organizations, including: the international board of
YPO, the Young President's Organization as International Event
Chair and winner of YPO's 2018 Best of the Best Award;
the Society of Independent Show Organizers; and as president
of the Philadelphia chapter of
YEO, the Young Entrepreneurs Organization.
Like tens of thousands of other Breakthrough T1D volunteers,
Matthew is passionately committed to helping to create a world
without T1D.
About Breakthrough T1D (formerly JDRF)
As the leading global type 1 diabetes research and advocacy
organization, Breakthrough T1D helps make everyday life with type 1
diabetes better while driving toward cures. We do this by
investing in the most promising research, advocating for progress
by working with government to address issues that impact the T1D
community, and helping educate and empower individuals facing this
condition.
About Type 1 Diabetes (T1D)
T1D is an autoimmune condition that causes the pancreas to make
very little insulin or none at all. This leads to dependence on
insulin therapy and the risk of short and long-term complications,
which can include highs and lows in blood sugar; damage to the
kidneys, eyes, nerves, and heart; and even death. Globally, it
impacts nearly 9 million people. Many believe T1D is only diagnosed
in childhood and adolescence, but diagnosis in adulthood is common
and accounts for nearly 50% of all T1D diagnoses. The onset of T1D
has nothing to do with diet or lifestyle. While its causes are not
yet entirely understood, scientists believe that both genetic
factors and environmental triggers are involved. There is currently
no cure for T1D.
Contact:
Chelsea-Lyn Rudder
646-946-0513
media@breakthroughT1D.org
View original content to download
multimedia:https://www.prnewswire.com/news-releases/breakthrough-t1d-proudly-announces-the-appointment-of-new-global-mission-board-chair-302192881.html
SOURCE JDRF International
